Corticosteroids and other immunosuppressants for immune-related adverse events and checkpoint inhibitor effectiveness in melanoma.
Saved in:
| Title: | Corticosteroids and other immunosuppressants for immune-related adverse events and checkpoint inhibitor effectiveness in melanoma. |
|---|---|
| Authors: | Verheijden RJ; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584CX Utrecht, the Netherlands; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, Heidelberglaan 100, 3584CX Utrecht, the Netherlands., Burgers FH; Divisions of Medical Oncology & Molecular Oncology & Immunology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands., Janssen JC; Department of Medical Oncology and Surgical Oncology, Erasmus Medical Centre, 's Gravendijkwal 230, 3015CE Rotterdam, the Netherlands., Putker AE; Department of Medical Oncology, Radboud University Medical Centre, Geert Grooteplein Zuid 10, 6525GA Nijmegen, the Netherlands., Veenstra SPGR; Department of Medical Oncology, Amsterdam UMC location VUmc, Cancer Center Amsterdam, De Boelelaan 1117, 1081HV Amsterdam, the Netherlands., Hospers GAP; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Hanzeplein 1, 9713GZ Groningen, the Netherlands., Aarts MJB; Department of Medical Oncology, GROW-School for Oncology and Reproduction, Maastricht University Medical Centre+, P. Debyelaan 25, 6229HX Maastricht, the Netherlands., Hehenkamp KW; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, 2333ZA Leiden, the Netherlands., Doornebosch VLE; Department of Internal Medicine, Medisch Spectrum Twente, Koningsplein 1, 7512KZ Enschede, the Netherlands., Verhaert M; Department of Medical Oncology, Laboratory of Medical and Molecular Oncology (LMM0), Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, 1090 Jette, Belgium., van den Berkmortel FWPJ; Department of Medical Oncology, Zuyderland Medical Centre, Dr. H. van der Hoffplein 1, 6162BG Sittard-Geleen, the Netherlands., Chatzidionysiou K; Rheumatology Unit, Department of Medicine, Karolinska Institute, 171 77 Stockholm, Sweden., Llobell A; R3 Rheumatology, Parc Taulí University Hospital, Sabadell, Barcelona 1-08208, Spain., Barros M; Department of Clinical Oncology, AC Camargo Cancer Center, R. Professor Antônio Prudente, 211 Liberdade, Sao Paulo, Brazil., Maria ATJ; Department of Internal Medicine, CHRU de Montpellier, 371 avenue du Doyen Gaston Giraud, 34090 Montpellier, France., Takeji A; Division of Rheumatology, Kanazawa University Hospital, Kanazawa University, 13-1 Takara-machi, Kanazawa, Ishikawa 920-8640, Japan., García Morillo JS; Unidad de Enfermedades Autoinmunes Sistemicas y Raras del Adulto, UGC Medicina Interna, Hospital Universitario Virgen del Rocío, Avda de Manuel Siurot s/n., 41013 Sevilla, Spain., Lidar M; Rheumatology Unit, Sheba Medical Center, Derech Sheba 2, Tel HaShomer, Israel., van Eijs MJM; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584CX Utrecht, the Netherlands; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Lundlaan 6, 3584EA Utrecht, the Netherlands., Blank CU; Department of Medical Oncology & Immunology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands., Aspeslagh S; Department of Medical Oncology, Laboratory of Medical and Molecular Oncology (LMM0), Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, 1090 Jette, Belgium., Piersma D; Department of Internal Medicine, Medisch Spectrum Twente, Koningsplein 1, 7512KZ Enschede, the Netherlands., Kapiteijn E; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, 2333ZA Leiden, the Netherlands., Labots M; Department of Medical Oncology, Amsterdam UMC location VUmc, Cancer Center Amsterdam, De Boelelaan 1117, 1081HV Amsterdam, the Netherlands., Boers-Sonderen MJ; Department of Medical Oncology, Radboud University Medical Centre, Geert Grooteplein Zuid 10, 6525GA Nijmegen, the Netherlands., van der Veldt AAM; Department of Medical Oncology and Radiology & Nuclear Medicine, Erasmus Medical Centre, 's Gravendijkwal 230, 3015CE Rotterdam, the Netherlands., Haanen JBAG; Divisions of Medical Oncology & Molecular Oncology & Immunology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, 2333ZA Leiden, the Netherlands; Melanoma clinic, Centre Hospitalier Universitaire Vaudois, Rue du Bugnon 23, 1011 Lausanne, Switzerland., May AM; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, Heidelberglaan 100, 3584CX Utrecht, the Netherlands., Suijkerbuijk KPM; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584CX Utrecht, the Netherlands. Electronic address: K.Suijkerbuijk@umcutrecht.nl. |
| Source: | European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Aug; Vol. 207, pp. 114172. Date of Electronic Publication: 2024 Jun 15. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38905818 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Corticosteroids and other immunosuppressants for immune-related adverse events and checkpoint inhibitor effectiveness in melanoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Verheijden+RJ%22">Verheijden RJ</searchLink>; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584CX Utrecht, the Netherlands; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, Heidelberglaan 100, 3584CX Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Burgers+FH%22">Burgers FH</searchLink>; Divisions of Medical Oncology & Molecular Oncology & Immunology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Janssen+JC%22">Janssen JC</searchLink>; Department of Medical Oncology and Surgical Oncology, Erasmus Medical Centre, 's Gravendijkwal 230, 3015CE Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Putker+AE%22">Putker AE</searchLink>; Department of Medical Oncology, Radboud University Medical Centre, Geert Grooteplein Zuid 10, 6525GA Nijmegen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Veenstra+SPGR%22">Veenstra SPGR</searchLink>; Department of Medical Oncology, Amsterdam UMC location VUmc, Cancer Center Amsterdam, De Boelelaan 1117, 1081HV Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Hospers+GAP%22">Hospers GAP</searchLink>; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Hanzeplein 1, 9713GZ Groningen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Aarts+MJB%22">Aarts MJB</searchLink>; Department of Medical Oncology, GROW-School for Oncology and Reproduction, Maastricht University Medical Centre+, P. Debyelaan 25, 6229HX Maastricht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Hehenkamp+KW%22">Hehenkamp KW</searchLink>; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, 2333ZA Leiden, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Doornebosch+VLE%22">Doornebosch VLE</searchLink>; Department of Internal Medicine, Medisch Spectrum Twente, Koningsplein 1, 7512KZ Enschede, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Verhaert+M%22">Verhaert M</searchLink>; Department of Medical Oncology, Laboratory of Medical and Molecular Oncology (LMM0), Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, 1090 Jette, Belgium.<br /><searchLink fieldCode="AU" term="%22van+den+Berkmortel+FWPJ%22">van den Berkmortel FWPJ</searchLink>; Department of Medical Oncology, Zuyderland Medical Centre, Dr. H. van der Hoffplein 1, 6162BG Sittard-Geleen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Chatzidionysiou+K%22">Chatzidionysiou K</searchLink>; Rheumatology Unit, Department of Medicine, Karolinska Institute, 171 77 Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Llobell+A%22">Llobell A</searchLink>; R3 Rheumatology, Parc Taulí University Hospital, Sabadell, Barcelona 1-08208, Spain.<br /><searchLink fieldCode="AU" term="%22Barros+M%22">Barros M</searchLink>; Department of Clinical Oncology, AC Camargo Cancer Center, R. Professor Antônio Prudente, 211 Liberdade, Sao Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Maria+ATJ%22">Maria ATJ</searchLink>; Department of Internal Medicine, CHRU de Montpellier, 371 avenue du Doyen Gaston Giraud, 34090 Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Takeji+A%22">Takeji A</searchLink>; Division of Rheumatology, Kanazawa University Hospital, Kanazawa University, 13-1 Takara-machi, Kanazawa, Ishikawa 920-8640, Japan.<br /><searchLink fieldCode="AU" term="%22García+Morillo+JS%22">García Morillo JS</searchLink>; Unidad de Enfermedades Autoinmunes Sistemicas y Raras del Adulto, UGC Medicina Interna, Hospital Universitario Virgen del Rocío, Avda de Manuel Siurot s/n., 41013 Sevilla, Spain.<br /><searchLink fieldCode="AU" term="%22Lidar+M%22">Lidar M</searchLink>; Rheumatology Unit, Sheba Medical Center, Derech Sheba 2, Tel HaShomer, Israel.<br /><searchLink fieldCode="AU" term="%22van+Eijs+MJM%22">van Eijs MJM</searchLink>; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584CX Utrecht, the Netherlands; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Lundlaan 6, 3584EA Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Blank+CU%22">Blank CU</searchLink>; Department of Medical Oncology & Immunology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Aspeslagh+S%22">Aspeslagh S</searchLink>; Department of Medical Oncology, Laboratory of Medical and Molecular Oncology (LMM0), Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, 1090 Jette, Belgium.<br /><searchLink fieldCode="AU" term="%22Piersma+D%22">Piersma D</searchLink>; Department of Internal Medicine, Medisch Spectrum Twente, Koningsplein 1, 7512KZ Enschede, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Kapiteijn+E%22">Kapiteijn E</searchLink>; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, 2333ZA Leiden, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Labots+M%22">Labots M</searchLink>; Department of Medical Oncology, Amsterdam UMC location VUmc, Cancer Center Amsterdam, De Boelelaan 1117, 1081HV Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Boers-Sonderen+MJ%22">Boers-Sonderen MJ</searchLink>; Department of Medical Oncology, Radboud University Medical Centre, Geert Grooteplein Zuid 10, 6525GA Nijmegen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+der+Veldt+AAM%22">van der Veldt AAM</searchLink>; Department of Medical Oncology and Radiology & Nuclear Medicine, Erasmus Medical Centre, 's Gravendijkwal 230, 3015CE Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Haanen+JBAG%22">Haanen JBAG</searchLink>; Divisions of Medical Oncology & Molecular Oncology & Immunology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, 2333ZA Leiden, the Netherlands; Melanoma clinic, Centre Hospitalier Universitaire Vaudois, Rue du Bugnon 23, 1011 Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22May+AM%22">May AM</searchLink>; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, Heidelberglaan 100, 3584CX Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Suijkerbuijk+KPM%22">Suijkerbuijk KPM</searchLink>; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584CX Utrecht, the Netherlands. Electronic address: K.Suijkerbuijk@umcutrecht.nl. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229005373%22">European journal of cancer (Oxford, England : 1990)</searchLink> [Eur J Cancer] 2024 Aug; Vol. 207, pp. 114172. <i>Date of Electronic Publication: </i>2024 Jun 15. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Ltd%22">Elsevier Science Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9005373 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-0852 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209598049%22">09598049 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38905818 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.ejca.2024.114172 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 114172 Titles: – TitleFull: Corticosteroids and other immunosuppressants for immune-related adverse events and checkpoint inhibitor effectiveness in melanoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Verheijden RJ – PersonEntity: Name: NameFull: Burgers FH – PersonEntity: Name: NameFull: Janssen JC – PersonEntity: Name: NameFull: Putker AE – PersonEntity: Name: NameFull: Veenstra SPGR – PersonEntity: Name: NameFull: Hospers GAP – PersonEntity: Name: NameFull: Aarts MJB – PersonEntity: Name: NameFull: Hehenkamp KW – PersonEntity: Name: NameFull: Doornebosch VLE – PersonEntity: Name: NameFull: Verhaert M – PersonEntity: Name: NameFull: van den Berkmortel FWPJ – PersonEntity: Name: NameFull: Chatzidionysiou K – PersonEntity: Name: NameFull: Llobell A – PersonEntity: Name: NameFull: Barros M – PersonEntity: Name: NameFull: Maria ATJ – PersonEntity: Name: NameFull: Takeji A – PersonEntity: Name: NameFull: García Morillo JS – PersonEntity: Name: NameFull: Lidar M – PersonEntity: Name: NameFull: van Eijs MJM – PersonEntity: Name: NameFull: Blank CU – PersonEntity: Name: NameFull: Aspeslagh S – PersonEntity: Name: NameFull: Piersma D – PersonEntity: Name: NameFull: Kapiteijn E – PersonEntity: Name: NameFull: Labots M – PersonEntity: Name: NameFull: Boers-Sonderen MJ – PersonEntity: Name: NameFull: van der Veldt AAM – PersonEntity: Name: NameFull: Haanen JBAG – PersonEntity: Name: NameFull: May AM – PersonEntity: Name: NameFull: Suijkerbuijk KPM IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2024 Aug Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1879-0852 Numbering: – Type: volume Value: 207 Titles: – TitleFull: European journal of cancer (Oxford, England : 1990) Type: main |
| ResultId | 1 |